Endure to Cure Pediatric Cancer Fo… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

Jason Sissel

Phone

8664002121

Tax Period

2024-01-01 to 2024-12-31

Endure to Cure Pediatric Cancer Foundation, founded in 2011, is a small nonprofit in the Medical Research sector that reported $361K in total revenue in fiscal year 2024. Revenue surged 24% from the prior year, signaling strong growth momentum.

Mission

Provide aid to pediatric cancer patients.

Program Service Accomplishments

Program 1

Expenses: $191,632

Our Travel for Treatment Assistance Grants help families cover immediate expenses associated with travel to their childs cancer treatment facilities. 580 Miscellaneous People. All unrelated parties.

Program 2

Expenses: $43,928

Our small miracles program provides uplifting gifts and experiences to children in cancer treatment and their families. This program helped approximately 164 beneficiaries. All unrelated parties.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $360,882

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $360,882

Expense Breakdown

Grants Paid $159,214

Salaries & Benefits $0

Fundraising Expenses $93,955

Program Expenses $235,560

Other Expenses $235,898

TOTAL EXPENSES $395,112

Year-over-Year Comparison

	2024	2023	Change
Revenue	$360,882	$290,797	+0.2%
Expenses	$395,112	$325,337	+0.2%
Net Income	$-34,230	$-34,540	0.0%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Jason Sissel	CEO	4.00	Officer Director	$0	$0	$0
Loukas Stephens	Treasurer	1.00	Officer Director	$0	$0	$0
Amanda Burrill	Director	1.00	Director	$0	$0	$0
Ismail Amin	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$360,882	$395,112	$8,030	$-34,230
2023	$290,797	$325,337	$12,260	$-34,540
2022	$250,149	$229,150	$6,800	$20,999
2019	$286,815	$278,526	$8,289	$8,289
2018	$212,035	$194,681	$31,701	$17,354

Endure to Cure Pediatric Cancer Foundation